Literature DB >> 32279289

Combined Pulmonary Fibrosis and Emphysema.

Maria Bolaki1, Katerina M Antoniou1.   

Abstract

Combined pulmonary fibrosis and emphysema (CPFE) is a clinical entity characterized by the combination of upper lobe emphysema and lower lobe fibrosis, the latter owing to various interstitial lung diseases. These patients have a characteristic lung function profile, with relatively preserved dynamic and static lung volumes, contrasting with a significant reduction of carbon monoxide transfer. The pathogenic mechanisms leading to the coexistence of emphysema with fibrosis remain unclear and different theories have been proposed. CPFE is frequently complicated by pulmonary hypertension, acute exacerbations, and lung cancer leading to poor natural history and prognosis. The syndrome of CPFE represents a distinct pulmonary manifestation in the spectrum of lung diseases associated with connective tissue diseases. Currently, there are no established recommendations regarding the management of patients with CPFE. We provide a review on the existing knowledge of CPFE regarding the epidemiology, pathogenesis, clinical manifestations, radiologic appearance, complications, prognosis, and possible treatment options. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2020        PMID: 32279289     DOI: 10.1055/s-0040-1708058

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  3 in total

1.  Development of a nomogram for predicting the presence of combined pulmonary fibrosis and emphysema.

Authors:  Xueting Yuan; Jin Jin; Xiaomao Xu
Journal:  BMC Pulm Med       Date:  2021-11-07       Impact factor: 3.317

2.  Comorbidities in unclassifiable interstitial lung disease.

Authors:  Thomas Skovhus Prior; Charlotte Hyldgaard; Sebastiano Emanuele Torrisi; Elisabeth Bendstrup; Michael Kreuter; Sissel Kronborg-White; Claudia Ganter
Journal:  Respir Res       Date:  2022-03-16

Review 3.  Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease.

Authors:  Joon Young Choi; Jin Woo Song; Chin Kook Rhee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.